Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study.

J Int Med Res · 2021 · PMC8381433 · PMID 34407681

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

Moreover, the p -value for benign prostatic hyperplasia medications between recurrence and non-recurrence groups was 0.09, indicating a slightly significant difference.

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.